In March 2021, approved emergency use.
Almaty leads in terms of the proportion of vaccinated in Kazakhstan as 45 percent of its population received the first dose, then the East Kazakhstan region 44.
These side effects usually fade away after 1—2 days.
It is useful for detecting and counting viruses by.
The published phase 1 and 2 trial data for the and vaccines show that most of the adverse events were common side effects and that none were serious.
By 4 June million doses had arrived and 6 million more were ordered.